Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dermorphin, (2-l-ala)-isomer
2. H-tyr-d-ala-phe-gly-tyr-pro-ser-nh2
3. Tyrosyl-alanyl-phenylalanyl-glycyl-tyrosyl-prolyl-serinamide
1. 77614-16-5
2. H-tyr-d-ala-phe-gly-tyr-pro-ser-nh2
3. (2s)-n-[(2s)-1-amino-3-hydroxy-1-oxopropan-2-yl]-1-[(2s)-2-[[2-[[(2s)-2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxamide
4. Chembl278789
5. 2sec01b703
6. Tyr-d-ala-phe-gly-tyr-pro-ser-nh2
7. Dermorphin Acetate
8. Tyrosyl-alanyl-phenylalanyl-glycyl-tyrosyl-prolyl-serinamide
9. Unii-2sec01b703
10. Yafgyps-nh2
11. Schembl237169
12. Tyr-ala-phe-gly-tyr-pro-ser
13. Dtxsid40228281
14. Chebi:177767
15. Hy-p0244
16. Bdbm50059841
17. Tyr-dala-phe-gly-tyr-pro-ser-nh2
18. Zinc95548678
19. C20030
20. Q1771654
21. L-serinamide, L-tyrosyl-d-alanyl-l-phenylalanylglycyl-l-tyrosyl-l-prolyl-
22. (s)-1-[(s)-2-[2-((s)-2-{(r)-2-[(s)-2-amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-acetylamino]-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic Acid ((s)-1-carbamoyl-2-hydroxy-ethyl)-amide
23. (s)-n-((s)-1-amino-3-hydroxy-1-oxopropan-2-yl)-1-((2s,8s,11r,14s)-14-amino-8-benzyl-2-(4-hydroxybenzyl)-15-(4-hydroxyphenyl)-11-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecane)pyrrolidine-2-carboxamide
24. 1-[2-[2-(2-{2-[2-amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-acetylamino]-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic Acid (1-carbamoyl-2-hydroxy-ethyl)-amide
25. 1-[2-[2-(2-{2-[2-amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-acetylamino]-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic Acid (1-carbamoyl-2-hydroxy-ethyl)-amide (dermorphin)
26. 1-[2-[2-(2-{2-[2-amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-acetylamino]-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic Acid (1-carbamoyl-2-hydroxy-ethyl)-amide(dermorphin)
27. Dermorphin;1-[2-[2-(2-{2-[2-amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-acetylamino]-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic Acid (1-carbamoyl-2-hydroxy-ethyl)-amide
Molecular Weight | 802.9 g/mol |
---|---|
Molecular Formula | C40H50N8O10 |
XLogP3 | 0 |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 19 |
Exact Mass | 802.36498982 g/mol |
Monoisotopic Mass | 802.36498982 g/mol |
Topological Polar Surface Area | 296 Ų |
Heavy Atom Count | 58 |
Formal Charge | 0 |
Complexity | 1410 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?